Baseline characteristics | Men (n = 359) | Women (n = 412) | P value |
---|---|---|---|
Age (years)* | 61.02 (0.56) | 60.06 (0.48) | 0.19 |
Systolic blood pressure (mmHg)* | 136.47 (0.88) | 140.96 (0.86) | <0.001 |
BMI (kg/m 2 )* | 27.8 (0.22) | 28.3(0.25) | 0.14 |
Total Cholesterol (mmol/L)* | 5.67 (0.06) | 6.0 (0.06) | <0.001 |
LDL Cholesterol (mmol/L)* | 3.47 (0.04) | 3.56 (0.037) | 0.10 |
HDL Cholesterol (mmol/L)* | 1.16 (0.015) | 1.41 (0.015) | <0.001 |
Triglycerides (mmol/L) †| 1.55 (1.15; 2.15) | 1.40 (1.04; 1.95) | 0.002 |
ApoA1 (g/L)* | 1.35 (0.011) | 1.53 (0.012) | <0.001 |
ApoB (g/L)* | 1.20 (0.013) | 1.19 (0.012) | 0.47 |
Antihypertensive Treatment (%) | 38.0% | 37.0% | 0.77 |
Antihyperlipidemic Treatment (%) | 21.5% | 16.6% | 0.08 |
Diabetes (%) | 17.3% | 9.5% | 0.001 |
No of MetS components (%) | Â | Â | Â |
        0 MetS Comp. | 5.3% | 12.9% | <0.001 |
        1 MetS Comp. | 19.6% | 35.0% | <0.001 |
        2 MetS Comp. | 29.1% | 28.4% | 0.38 |
        3 MetS Comp. | 25.4% | 18.2% | 0.21 |
        4 MetS Comp. | 17.0% | 4.4% | <0.001 |
        5 MetS Comp. | 3.6% | 1.2% | 0.059 |